Innophos Holdings, Inc. (NASDAQ:IPHS) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating. Innophos’ rating score has improved by 50% in the last three months as a result of various analysts’ ratings changes.
Brokerages have set a 12-month consensus target price of $46.00 for the company and are predicting that the company will post $0.53 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Innophos an industry rank of 218 out of 255 based on the ratings given to its competitors.
IPHS has been the subject of several analyst reports. BidaskClub lowered shares of Innophos from a “buy” rating to a “hold” rating in a research note on Thursday, October 10th. ValuEngine upgraded shares of Innophos from a “sell” rating to a “hold” rating in a research note on Saturday, September 14th. Finally, Zacks Investment Research upgraded shares of Innophos from a “sell” rating to a “hold” rating in a research note on Wednesday, October 9th.
NASDAQ:IPHS traded down $0.16 on Tuesday, hitting $34.92. The stock had a trading volume of 84,700 shares, compared to its average volume of 99,431. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.41 and a current ratio of 2.85. The stock has a market cap of $623.42 million, a P/E ratio of 15.32 and a beta of 1.44. Innophos has a 1 year low of $22.57 and a 1 year high of $36.00. The firm’s fifty day simple moving average is $31.17 and its two-hundred day simple moving average is $29.51.
Innophos (NASDAQ:IPHS) last posted its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $0.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.06. The firm had revenue of $185.04 million during the quarter, compared to analyst estimates of $196.55 million. Innophos had a net margin of 3.79% and a return on equity of 12.35%. The company’s revenue for the quarter was down 10.5% on a year-over-year basis. During the same quarter last year, the business posted $0.55 EPS. Equities research analysts predict that Innophos will post 2.18 EPS for the current year.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Further Reading: Book Value Of Equity Per Share – BVPS Explained
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.